Barely Significant
← all phrases

nominally significant

5,450 sentences · 5,450 papers · 9,414 search hits before verification · confirmed specimen

Sighted at

p=0.08

Listed by Hankins (2013) · Otte et al. (2022)

In the literature

nominally significantp<0.051.0× alphagold
While on the whole, none of the cis -SNPs were genome-wide significant in the GWAS data, they were significantly enriched for nominally significant (p<0.05) SNPs in the BMI GWAS results ( [65] , binomial p = 0.007), indicating either their pleiotropic effect, or metabolic trait regulation through small RNA expression levels. rs2440129 was nominally significant in the BMI GWAS lookup [65] , while mir-195-3p was significantly associated with both rs2440129 in cis (FDR<5%, p<2.4×10 −5 ), as well as BMI (FDR<5%, p<3.9×10 −3 ) and PTFM (FDR<5%, p<4.1×10 −3 ), suggesting a mechanism for the rs2440129 association.
nominally significantp < 0.051.0× alphagold
The levels of all proteins (regardless of storage-time) with nominally significant ( p < 0.05) contributions were subsequently adjusted for age and/or plasma/serum by removing the contribution using the beta (β)-coefficient(s) from the linear models.
Stability of Proteins in Dried Blood Spot Biobanks.
Mol Cell Proteomics · 2017 · PMC5500761
nominally significantP < 0.051.0× alphagold
In addition, rs713998 showed a nominally significant ( P < 0.05) association with verbal memory, and this association did not remain after Bonferroni correction (verbal memory subtest score: A/A and A/G = −1.74 ± 1.28, G/G = −2.19 ± 1.31, β = 0.210, t = 2.704, permutation P value = 0.029).
nominally significantP < 0.051.0× alphagold
Eight of the 13 ALFRED genes with a nominally significant association between RDGVs and AI in at least one cancer type in the ALFRED analysis ( P < 0.05; Fig. 2d and Supplementary Data 5 ) also had an enrichment of RDGVs in a matched cancer type compared to in controls ( P < 0.05, Fig. 3d ; Supplementary Data 6 ): ATM in colon and rectum adenocarcinoma (COADREAD), lung adenocarcinoma (LUAD) and in PRAD, NSD1 in OV, and TPCN2 in uterine corpus endometrial carcinoma (UCEC).